Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-08-16

Clinical Trial Update: Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis

View source ↗

Summary

This update reports on pharmacogenomics research related to anti-TNF therapy in rheumatoid arthritis. It examines how genetic factors may influence treatment re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Radboud University Medical Center | Conditions: Rheumatoid Arthritis | Status: UNKNOWN